Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.
For patients with advanced liver cancer, especially those with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD), which is caused by a high-fat diet, treatment ...
TwistedSifter on MSN
How henna could form the unlikely basis for a treatment that may save the lives of liver fibrosis sufferers
But by a wonderful quirk of nature, this fascinating chemical compound was found to inhibit the activation of hepatic ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
AIX-EN-PROVENCE, France--(BUSINESS WIRE)--E-Scopics, the France-based medical ultrasound company and creator of a unique software-based liver assessment tool, welcomed the announcement that Madrigal ...
Semaglutide is a prescription medication used to treat type 2 diabetes. It may also help people with overweight or obesity lose weight, and it may help reduce fat buildup in the liver. Semaglutide ...
MedPage Today on MSN
Liver Cancer Treatment Landscape Shifts Rapidly, but Best Sequencing Still Unclear
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...
Please provide your email address to receive an email when new articles are posted on . Metabolic dysfunction-associated steatotic liver disease is a public health threat, affecting 30% to 38% of the ...
The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...
Several medications can treat cirrhosis. Your doctor will choose the right one for you depending on your overall health, any allergies, and other important factors. Cirrhosis is a liver condition that ...
The current method for assessing medication-related liver injury is not providing an accurate picture of some medications' toxicity - or lack thereof - to the liver, according to a new study led by ...
Australians living with a range of debilitating conditions including juvenile arthritis, rare liver disease and multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results